Psoriasis vulgaris associated with systemic lupus erythematosus successfully treated with apremilast

J Dermatol. 2019 Jun;46(6):e219-e221. doi: 10.1111/1346-8138.14728. Epub 2018 Dec 10.

Authors

Susumu Ichiyama¹, Toshihiko Hoashi¹, Naoko Kanda², Hiroshi Hashimoto³, Masakazu Matsushita³, Kazuhisa Nozawa³, Takashi Ueno⁴, Hidehisa Saeki¹

Affiliations

¹ Department of Dermatology, Nippon Medical School, Tokyo, Japan.
² Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan.
³ Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
⁴ Department of Dermatology, Nishi-Omiya Hospital, Saitama, Japan.

PMID: 30536461
DOI: 10.1111/1346-8138.14728

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Adult
Antibodies, Antinuclear / blood
Drug Therapy, Combination / methods
Female
Humans
Lupus Erythematosus, Systemic / blood
Lupus Erythematosus, Systemic / complications
Lupus Erythematosus, Systemic / drug therapy*
Phosphodiesterase 4 Inhibitors / administration & dosage*
Prednisolone / administration & dosage
Psoriasis / complications
Psoriasis / diagnosis
Psoriasis / drug therapy*
Severity of Illness Index
Thalidomide / administration & dosage
Thalidomide / analogs & derivatives*
Treatment Outcome

Substances

Antibodies, Antinuclear
Phosphodiesterase 4 Inhibitors
Thalidomide
Prednisolone
apremilast